Essays and evidence on ageing, from LONGEVITY’s doctors and specialists.

Three-panel illustration comparing weight loss with exercise-related vascular stimulation and measured vascular outcomes.

Weight loss is not the finished job

Getting lighter is useful. Becoming stronger, fitter and metabolically healthier is a larger ambition. Research combining exercise and liraglutide[…]

Illustration of transcranial near-infrared light, a proposed mitochondrial mechanism and cognitive results from a small trial.

Can light change human biology?

A small randomised trial of near-infrared light reported cognitive improvements in people with mild cognitive impairment. The result is[…]

Diagram showing how CDK4/6 inhibition with abemaciclib may reduce inflammatory signalling from senescent cells.

Senescent cells: silence them or clear them?

Removing senescent cells is only one possible strategy. Preclinical research suggests that changing their inflammatory behaviour may also matter,[…]

Diagram linking the mitochondrial peptide MOTS-c to adaptive signalling and metabolic effects in muscle.

MOTS-c: mitochondrial signalling enters the clinic

MOTS-c offers a window into mitochondria as signalling systems. A clinical trial brings that biology closer to patients, while[…]

Three-panel diagram of coronary perivascular fat, proposed dapagliflozin effects and a hypothesised coronary benefit.

The inflammatory tissue around our arteries

The fat surrounding an artery is an active signalling environment. A dapagliflozin trial asks whether changing that environment could[…]

Three-panel illustration contrasting vascular ageing, intermittent fisetin dosing and a monitored senolytic strategy.

Fisetin: serious biology, not pixie-dust dosing

Fisetin research asks whether intermittent senolytic treatment can improve ageing vascular biology. The evidence remains early, but it deserves[…]